antisense

Related by string. Antisense * * approaches AVI antisense . antisense drug . antisense drugs . generation antisense . antisense oligonucleotide . antisense oligonucleotides . antisense RNA . uses NEUGENE antisense . Antisense Therapeutics . antisense therapeutics . antisense compounds . generation NEUGENE antisense . NEUGENE antisense . NEUGENE antisense compound *

Related by context. All words. (Click for frequent words.) 70 Antisense 68 siRNA 68 antisense drugs 67 antisense drug 67 antisense oligonucleotides 67 HDAC 67 gene silencing 66 siRNA therapeutics 66 histone deacetylase inhibitors 66 PARP inhibitors 66 RNAi 65 siRNA delivery 65 molecularly targeted 65 targeting CD# 65 VEGF receptor 65 exon skipping 64 miR #a [002] 64 BCR ABL 64 antisense compounds 64 small molecule 64 Hedgehog pathway 64 kinase inhibitors 63 siRNAs 63 JAK3 63 Hedgehog signaling pathway 63 HDAC inhibitors 63 small interfering RNA 63 nucleoside 63 MEK inhibitors 63 aptamers 63 RNA silencing 63 RNA interference 63 oligonucleotide 63 selective inhibition 63 microRNA 63 oncolytic viruses 63 NexACT 62 lentiviral vector 62 small molecule inhibitors 62 antisense oligonucleotide 62 recombinant protein 62 JAK inhibitors 62 anticancer agents 62 Aurora kinase 62 anti angiogenic 62 PI3K inhibitors 62 WT1 62 cancer immunotherapies 62 Nanobody 62 Fleximer 62 proteasome inhibitors 62 CTLA 4 62 vascular disrupting agents 62 IGF 1R 62 geldanamycin 62 PI3K inhibitor 62 antitumor 62 humanized monoclonal antibodies 62 EGF receptor 62 peptide 62 Affinitak 61 proteasome inhibitor 61 generation antisense 61 taxol 61 oncolytic 61 AtuRNAi 61 UsiRNAs 61 miR #b [002] 61 integrase 61 siRNA therapeutic 61 stable nucleic acid 61 anti angiogenesis 61 antibody 61 immune modulation 61 IAP inhibitors 61 PI3 kinase 61 FLT3 61 anticancer therapies 61 Sphingomab 61 topoisomerase 61 EphA2 61 FGFR 61 antibody fragment 61 kinase inhibitor 61 miRNA 61 #ME# 61 humanized antibodies 60 PCSK9 60 PLX# 60 seliciclib 60 histone deacetylase HDAC 60 tyrosine kinase inhibitor 60 short interfering RNA 60 antiviral compounds 60 NF kappa B 60 fusion proteins 60 Hsp# inhibitors 60 endostatin 60 preclinically 60 RNA interference RNAi 60 DiLA2 60 novel peptide 60 trans splicing 60 ADAM# 60 multitargeted 60 survivin 60 angiogenesis inhibitor 60 CCX# 60 anticancer therapeutics 60 DsiRNA 60 mTOR inhibitors 60 PI3K 60 novel immunomodulatory 60 kinase 60 chemokine 60 anticancer 60 synthetic peptide 60 OXi# 60 Locked Nucleic Acid LNA 60 DFMO 60 VEGF 60 Janus kinase 60 ghrelin receptor 60 epothilone 60 antagomirs 60 peptide antigens 60 hedgehog pathway 60 peptides 60 NEUGENE 60 PDGF receptor 60 Panzem 60 Hsp# inhibition 60 potent anticancer 60 CCR3 60 interferon 60 gene therapy 59 LRRK2 59 LEX System 59 IFN alpha 59 aptamer 59 interferon lambda 59 BiTE 59 otelixizumab 59 Onconase 59 MLN# 59 DLC1 59 TLR8 59 E#F# 59 Tarvacin 59 tumor antigen 59 TRAIL receptor 59 BRAF inhibitor 59 immunomodulatory 59 TLR9 59 Stapled Peptide 59 GSK3 59 AAV vectors 59 siRNA compounds 59 Protein Kinase C 59 protein kinase inhibitor 59 Symadex 59 T#I [002] 59 immunomodulator 59 HSP# inhibitor 59 anti angiogenic agent 59 synthetic peptides 59 CCR2 59 antisense inhibition 59 fusion protein 59 micro RNAs 59 chemically modified siRNA 59 interferons 59 GRN#L 59 c myc 59 monoclonal antibodies 59 JAK1 59 GGTase 59 iPSC 59 gamma secretase 59 TAp# 59 sigma receptors 59 BRAF kinase 59 siRNA mediated 59 SMaRT ™ 59 engineered RAP peptides 59 paclitaxel Taxol 59 CA4P 59 estrogen receptor beta 59 antiangiogenic 59 EGFr 59 polymerase inhibitors 59 ALK inhibitor 59 ErbB3 59 poly ADP ribose polymerase 59 monoclonal antibody 59 ribonuclease 59 immunotoxins 59 erlotinib Tarceva 59 pharmacological chaperone 59 Factor VIIa 59 PKM2 59 antiangiogenesis 59 HuLuc# 59 HCV replication 59 CYC# 59 virus AAV 59 humanized antibody 59 MAXY G# 59 telomerase 59 immunotherapy 59 SOD1 59 novel anticancer 59 enzyme inhibitor 59 orally bioavailable 59 MUC1 59 immunotherapeutics 59 anti CD3 59 deacetylase inhibitors 59 TLR9 agonist 59 JAK inhibitor 58 anti CD# antibodies 58 ENMD # 58 interfering RNAs 58 small molecule activators 58 micro RNA 58 NEUGENE R 58 PEGylated 58 PEGylation 58 isoform selective 58 chemotherapeutic agents 58 integrase inhibitors 58 HDAC inhibition 58 TLR Therapeutics 58 Gleevec resistant 58 Eg5 58 LY# [003] 58 nucleosides 58 PARP inhibitor 58 ZFNs 58 delta isoform 58 chemokine receptor 58 anti VEGF 58 small molecule agonists 58 RNAi therapeutic 58 RNAi therapeutics 58 CBLC# 58 rhIL 7 58 chimeric 58 AVI NEUGENE 58 CXCR4 58 Flt3 58 TLR9 agonists 58 taxanes 58 HSP# inhibitors 58 pegylated 58 S#P# 58 GPCR targets 58 sphingolipid 58 biologic therapeutics 58 EZN 58 IGFBP2 58 Fc fusion protein 58 chemotherapeutics 58 PEG SN# 58 viral vector 58 cyclophilin D 58 tumor suppressor protein 58 ganetespib 58 stapled peptides 58 cytostatic 58 immunotherapies 58 SERMs 58 TLR7 58 Clusterin 58 immune stimulatory 58 microRNAs 58 gamma secretase inhibitors 58 G Protein Coupled 58 DHFR 58 vimentin 58 HDAC6 58 Tarvacin TM 58 CHO cells 58 VEGFR2 58 flavopiridol 58 tyrosine kinases 58 interferon beta 58 intracellular signaling pathways 58 small molecule inhibitor 58 ubiquitin ligases 58 nucleoside analogues 58 peroxisome proliferator activated 58 MEK inhibitor 58 pertuzumab 58 A3 adenosine receptor 58 rxRNA 58 lentiviral vectors 58 small molecule defensin 58 immunoregulatory 58 histone deacetylase HDAC inhibitors 58 Sym# 58 antisense RNA 58 multi kinase inhibitor 58 Tß4 58 druggable targets 58 alpha interferon 58 Curaxin 58 triterpenoids 58 HER3 58 bryostatin 58 liposomal formulation 58 Mipomersen 58 Wnt signaling pathway 58 PDGFR 58 viral vectors 58 lipid nanoparticles 58 GPR# [002] 58 signal transduction inhibitor 58 STAT3 58 liposomal 58 MDM2 58 HCV protease 58 Hsp# inhibitor 58 ATL# [001] 57 selective inhibitors 57 mda 7 57 proprietary LNA 57 integrase inhibitor 57 RNA 57 MetMAb 57 tyrosine kinase inhibitors 57 defensins 57 HepDirect 57 potently inhibit 57 JAK2 57 UsiRNA 57 JAK2 inhibitor 57 Aganocide ® 57 synthetic retinoid 57 replicon 57 shRNA 57 mAbs 57 CobaCyte 57 microRNAs miRNAs 57 Fleximer R 57 apoE 57 small interfering RNAs 57 miRNAs 57 OncoVEX 57 Cyclosert 57 adenoviral 57 immunotherapeutic 57 novel peptides 57 Survivin 57 tranilast 57 BRAF inhibitors 57 ddRNAi 57 neuroprotective 57 oxidative stress inducer 57 ENaC 57 MVA BN R 57 TMEM#B 57 HDAC inhibitor 57 NFkB 57 splice variant 57 VEGF inhibitors 57 histone deacetylase 57 epigenetic therapies 57 electroporation 57 oligonucleotide therapeutics 57 CCR5 57 C5aR 57 obatoclax 57 microtubule targeting 57 cytotoxic agents 57 PDE4 inhibitor 57 derived neurotrophic factor 57 sphingosine 1 57 inhibit viral replication 57 epothilones 57 mGluR5 antagonist 57 AMPAKINE 57 vorinostat 57 E1A 57 selectively inhibit 57 chemoresistance 57 nucleoside analog 57 Nanobody ® 57 HIF 1alpha 57 MicroRNA 57 androgen receptor 57 cancer immunotherapy 57 adoptive immunotherapy 57 chemotherapeutic drug 57 FUS1 57 immunotoxin 57 morpholino 57 bioactive lipids 57 ErbB 57 NS4A 57 retinoic acid 57 HIV protease 57 therapeutic antibody 57 EGFR 57 idarubicin 57 Nanobodies 57 lipid particles 57 lentivirus 57 LNP formulations 57 nucleoside analogue 57 neurotrophic factor 57 Anticalin 57 hypoxia inducible factor 57 Anticalin R 57 tRNA synthetase 57 ZFN technology 57 Vpu 57 PI3K/mTOR 57 immunostimulatory 57 VEGFR 57 c MYC 57 HCV protease inhibitors 57 Axitinib 57 molecular chaperone 57 nonviral 57 Isis antisense 57 induce apoptosis 57 p# subunit 57 GPCR 57 CENP E 57 therapeutic monoclonal antibodies 57 CXCR4 receptor 57 histone methyltransferases HMTs 57 Rapamycin 57 galectin 57 Abiraterone 57 peptidic 57 ISIS # 57 RNA antagonist 57 Notch1 57 integrase enzyme 57 TLR agonists 57 TLE3 57 Ii Key 57 monoclonals 56 miR #a [001] 56 calcineurin 56 Alnylam RNAi 56 antitumoral 56 lentiviral 56 RNAi therapeutic targeting 56 systemic RNAi 56 vascular disrupting agent 56 nanoviricides 56 anionic backbone 56 ZFP TFs 56 Tyrima 56 Scancell 56 enzyme inhibitors 56 IDH1 56 prodrug 56 alkylating agent 56 BMS # 56 Isis Pharmaceuticals 56 nucleotide analogs 56 Galectin 56 Anticalins ® 56 Abl 56 interfering RNA 56 polymerase inhibitor 56 ALN TTR 56 LY# [002] 56 ribonucleic acid RNA 56 decitabine 56 angiogenesis inhibitors 56 TNFa 56 dsRNA 56 mTOR inhibition 56 Pertuzumab 56 humanized anti 56 heterodimers 56 REP# 56 resolvins 56 rxRNA compounds 56 glucocorticoid receptor 56 FGFR1 56 GAP #B# 56 NS5A 56 tkRNAi 56 GPCRs 56 drug conjugate 56 subtype selective 56 daclizumab 56 miR 56 Olaparib 56 peptide fragments 56 GMX# 56 OMP #M# 56 ligases 56 Bcl 2 56 preclinical studies 56 INGN 56 anticancer agent 56 Angiolix 56 HuMax CD# 56 Ii protein 56 TNFα 56 acetylcholinesterase AChE 56 XmAb# 56 PI3K delta 56 nutlin 56 AKIP 56 protease inhibitors 56 HCV NS3 protease 56 Nanobodies ® 56 LEP ETU 56 imatinib Gleevec 56 inhibit replication 56 NF kB 56 oral antiviral 56 Guanilib 56 metaglidasen 56 Tumor Necrosis Factor 56 bevacizumab Avastin ® 56 B Raf 56 uPAR 56 ZFP TF 56 antisense molecules 56 therapeutic antibodies 56 RNA ribonucleic acid 56 noncoding RNAs 56 thrombin receptor 56 anti angiogenic drugs 56 serotonin receptor 56 Homspera 56 RNA Interference 56 dAbs 56 Targretin 56 RNA antagonists 56 oncoprotein 56 atacicept 56 milatuzumab 56 adenovector 56 sodium glucose cotransporter 56 antisense inhibitors 56 mitotic kinesins 56 cyclin D1 56 potent inhibitor 56 enzastaurin 56 PKCi 56 metalloenzymes 56 preclinical compounds 56 Liposomal 56 short hairpin RNAs 56 SIRT1 activators 56 FAAH 56 XL# inhibits 56 tyrosine kinase 56 Viprovex TM 56 VEGFb 56 apoptotic pathway 56 agonist compounds 56 P#X# 56 NTDDS 56 Akt1 56 short hairpin RNA 56 ERK pathway 56 single stranded oligonucleotides 56 protein misfolding 56 GSOs 56 OXIGON TM 56 sorafenib Nexavar 56 small RNAs 56 liposomal delivery 56 CCR1 56 interferon alpha 56 NS4B 56 AAV2 56 RAR beta 56 meganucleases 56 Affibody 56 small molecule tyrosine 56 alternatively spliced 56 serine threonine kinase 56 phosphate S1P 56 Debio 56 HCV protease inhibitor 56 gamma secretase inhibitor 56 bispecific antibody 56 HuCAL antibody 56 neuropilin 56 neuroprotection 56 pegylation 56 noncoding RNA 56 polyketides 56 glycosylated 56 DNA plasmids 56 siRNA molecules 56 lipid nanoparticle 56 eIF4E 56 antiviral therapies 56 allosteric 56 BiTE antibodies 56 synthetic lethality 56 EGFR pathway 56 HGS# 56 antisense inhibitor 56 antibody cytokine 56 Fibroblast Growth Factor Receptor 56 renin inhibitors 56 effector function 56 elesclomol 56 HER1 56 plasmid DNA vaccine 56 Bezielle 56 insulin sensitizing 56 Elvitegravir 56 enzymatic activity 56 SIRT2 56 Doxil 56 oligonucleotides 56 interferon IFN 56 Htt 56 Neugene 56 vivo RNAi 56 hTERT 56 transdifferentiation 56 Fc receptor 56 LentiVector technology 56 tyrosine kinase receptor 56 oncolytic virus 56 histone deacetylase HDAC inhibitor 56 eniluracil 56 cytokine signaling 56 neuroprotective properties 55 mTOR inhibitor 55 thyroid hormone receptor 55 Factor Receptor 55 HDAC enzymes 55 chemopreventive 55 protein kinase C 55 Novosom 55 RIP1 kinase 55 cholesteryl ester transfer 55 HER-2/neu 55 NF kB pathway 55 phage display 55 YONDELIS 55 phosphorylate 55 siRNA sequences 55 BCL6 55 mGluR4 55 mTOR 55 IL 1beta 55 ZFN 55 pRb 55 mimetics 55 EGFR tyrosine kinase inhibitors 55 thymidylate synthase TS 55 gefitinib Iressa 55 HIV protease inhibitors 55 epitope 55 parthenolide 55 Fenretinide 55 homologous recombination 55 histone deacetylases 55 AEG# 55 USP# 55 transgene expression 55 T DM1 55 bortezomib 55 thrombopoietin 55 angiogenesis inhibition 55 kallikrein 55 XmAb 55 chemotherapeutic agent 55 bevirimat 55 vinblastine 55 Imatinib 55 Hybridon 55 teplizumab 55 cyclin E 55 AEZS 55 cannabinoid 55 induces apoptosis 55 Cylene 55 protein therapeutics 55 zinc finger nuclease 55 polypeptide 55 molecularly targeted therapies 55 pro apoptotic 55 kinases 55 galectins 55 entinostat 55 anticancer drugs 55 tyrosine phosphorylation 55 BCR ABL inhibitors 55 theranostic 55 p# MAPK 55 BZL# 55 tumor specific antigen 55 Celator 55 Aurora Kinase 55 Curaxins 55 immune modulatory 55 HER2 receptor 55 disease modifying 55 TLR3 55 myeloma cells 55 CEQ# 55 HDACi 55 HDACs 55 Skp2 55 PDE4 inhibitors 55 rAAV 55 alpha synuclein 55 cell signaling pathways 55 5 lipoxygenase 55 thymidylate synthase 55 multidrug resistance 55 PCK# 55 endothelin receptor 55 Carfilzomib 55 LPA1 receptor 55 NEUGENE antisense 55 Janus Kinase 55 LPA1 55 SGLT2 inhibitors 55 cytotoxic 55 nucleoside analogs 55 NF κB 55 potent inhibitors 55 antimicrobial peptides 55 orally dosed 55 reverse transcriptase 55 Angiocept 55 EZH2 55 AMN# [001] 55 Alfacell proprietary ribonuclease 55 Trastuzumab 55 lipidoid 55 Kv#.# 55 myelofibrosis polycythemia vera 55 vanilloid receptor 55 NNRTIs 55 axitinib 55 Dapagliflozin 55 Mcl 1 55 uPA 55 anti CD3 antibody 55 immunomodulators 55 TNF α 55 TGF ß 55 neurite outgrowth 55 activin 55 JAK#/JAK# 55 cyclin dependent kinases 55 JAK3 inhibitor 55 JAK kinases 55 alpha synuclein gene 55 incretin 55 RNase H 55 MediVas 55 RNase L 55 cyclin dependent kinase inhibitor 55 rBChE 55 therapeutic monoclonal antibody 55 COX2 55 Cobalamin 55 PXD# 55 proprietary PEGylation 55 PTC# 55 immunomodulating 55 secreted protein 55 ALN PCS 55 immune modulator 55 novel RNAi therapeutics 55 SNALP 55 NITD# 55 gastrin 55 Spiegelmers ® 55 eIF 4E 55 glucagon receptor 55 cyclooxygenase 55 Kinase Inhibitor 55 cytoprotective 55 Anticalins R 55 virotherapy 55 pomalidomide 55 selective kinase inhibitor 55 pan HDAC inhibitor 55 selective kinase inhibitors 55 adhesion molecule 55 NXL# 55 protein kinases 55 ErbB3 HER3 55 HGS ETR1 55 pro angiogenic 55 RNAi mediated 55 #beta HSD 1 55 CORT # 55 Paclitaxel 55 receptor tyrosine kinase 55 cancer therapeutics 55 delafloxacin 55 Omacetaxine 55 Syk 55 DepoVax TM 55 BioSilicon 55 Everolimus 55 EndoTAG TM 55 Locked Nucleic Acid 55 PTPN# 55 GeneICE 55 Interferon 55 BAY #-# 55 nanoparticle 55 clusterin 55 PI3 K 55 Sanger sequencing 55 enveloped viruses 55 Regado 55 Dasatinib 55 TGF beta 55 Metallophile ™ Technology 55 oral prodrug 55 Squalamine 55 Nedd4 55 antibody therapeutics 55 LNPs 55 ligand 55 AMPAKINE compounds 55 DNA gyrase 55 gene amplification 55 bispecific 55 functional genomics 55 Vidofludimus 55 #beta HSD1 55 PARP inhibition 55 PKC# 55 Hsp# [002] 55 AP# [003] 55 Preclinical studies suggest 55 echinocandins 55 mertansine 55 EGFRvIII 55 immunogens 55 Epothilones 55 TrkA 55 HER2/neu 55 siRNA constructs 55 TG# [003] 55 serine protease 55 Xencor XmAb 55 GRP# 55 oral JAK1 55 c MET 55 Sudhir Agrawal D.Phil 55 chemotherapeutic drugs 55 IGF1R 55 2' O 55 therapeutics 55 mRNA antagonists 55 Etubics 55 siRNA molecule 55 VEGF Trap 55 TGF β 55 microRNA therapeutics 55 CDDO Im 55 CDK4 55 BiTE antibody 55 intracellular protein 55 receptor antagonists 55 PAK1 55 inhibit tumor 55 galectin 3 54 Hedgehog inhibitor 54 cyclopamine 54 NPM1 54 SGLT 54 anticancer compounds 54 vascular endothelial growth 54 MAb 54 Intellect Neurosciences 54 dexpramipexole 54 immunosuppressive 54 cediranib 54 CRAC channel 54 GM CSF 54 cytotoxic T lymphocyte 54 RNA therapeutics 54 CTLA4 Ig 54 Irinotecan 54 FTIs 54 Wnt 54 eotaxin 54 Factor 5A 54 NIC5 54 GPR# [001] 54 perifosine 54 telomerase inhibitors 54 FK# 54 secreted proteins 54 muscarinic 54 nanocarrier 54 metabolic enzymes 54 Hedgehog signaling 54 neuroprotectant 54 2DG 54 SGLT2 54 MUC1 * 54 preclinical 54 Anticalin ® 54 Dicer Substrate Technology 54 HIF 1α 54 brostallicin 54 cyclosporin 54 DOS# 54 FasL 54 siRNA binds 54 KineMed 54 DECIPHER R 54 ArQule Kinase Inhibitor Platform 54 SARMs 54 S1P 54 cilengitide 54 ON #.Na 54 dimerization 54 polypeptides 54 virulence genes 54 Vascular Endothelial Growth 54 Chemokine Receptor 54 TELINTRA 54 RANKL 54 ERK1 2 54 molecular mimicry 54 rifamycins 54 Th# 54 DNAi 54 ANGPTL4 54 splice variants 54 PEG Interferon lambda 54 Lodamin 54 taxane 54 IL #R 54 CYT# 54 Anticalins 54 CCR5 antagonists 54 BAL# [001] 54 p# inhibitor 54 anticoagulant reversing agent 54 EGFR inhibitors 54 DCVax R 54 CD#L 54 pRNA 54 c myb 54 LentiVector 54 CXCR7 54 sarcosine 54 Zolinza 54 p#/CBP 54 vaccine adjuvant 54 mitogen activated protein kinase 54 xenograft models 54 phosphatases 54 allosteric modulation 54 glioma cells 54 c Myc 54 cannabinoid receptor 54 microRNA miRNA 54 Th2 cytokines 54 Cyclosert TM 54 receptor modulators 54 tumor hypoxia 54 non coding RNA 54 anti angiogenic therapies 54 investigational humanized monoclonal antibody 54 iRGD 54 THR beta agonist 54 Crizotinib 54 AT1R 54 hES cells 54 CGEN # 54 neurodegenerative diseases 54 antimetastatic 54 MVA BN 54 Peptide 54 ocrelizumab 54 SGLT 2 54 RNAi compounds 54 recombinant antibodies 54 estrogen receptor 54 FGFR3 54 sd rxRNA 54 Bortezomib 54 Lpathomab 54 predictive biomarkers 54 HSP# 54 endogenous ligands

Back to home page